Market revenue in 2022 | USD 678.6 million |
Market revenue in 2030 | USD 784.8 million |
Growth rate | 1.8% (CAGR from 2022 to 2030) |
Largest segment | Dietary supplements |
Fastest growing segment | OTC pharma products |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | OTC pharma products, Dietary Supplements |
Key market players worldwide | Bayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis |
Dietary supplements was the largest segment with a revenue share of 96.05% in 2024. Horizon Databook has segmented the Canada menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
There is an increase in awareness about dietary requirements, leading to a greater demand for them among older women. A study was conducted to assess the availability of Over-the-counter (OTC) Natural Health Products (NHPs) to Canadian women.
Published by BMC Complementary Medicine and Therapies in March 2015, the study reviewed stores in Edmonton city belonging to nine different pharmacy chains. It found that out of 20 products, around 19 had Canada license numbers and were easily available to women.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account